Eveliqure Biotechnologies

Eveliqure is a vaccine company championing novel technologies to make the world safe from diarrhoeal diseases. Addressing this health problem, endemic in resource-poor countries, is vital, as it is a leading cause of child mortality in the world, impacts travelers, and costs billions of dollars to address. Eveliqure developed a combined vaccine, deemed to be the ideal scenario by the World Health Organization.

Gabor Somogyi, MBA ’03